Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-09 Sale | 2020-06-10 5:26 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 9,500 | $65.81 | $625,194 | 1,841,681 (Indirect Direct) | View |
| 2020-06-04 Sale | 2020-06-08 8:26 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $64.16 | $3,560,648 | 1,851,181 (Indirect Direct) | View |
| 2020-05-19 Sale | 2020-05-21 7:05 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $59.18 | $1,242,703 | 1,906,681 (Indirect Direct) | View |
| 2020-05-08 Sale | 2020-05-12 8:09 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $53.86 | $619,351 | 1,927,681 (Indirect Direct) | View |
| 2020-05-05 Sale | 2020-05-07 6:52 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $53.27 | $2,956,634 | 1,939,181 (Indirect Direct) | View |
| 2020-04-22 Sale | 2020-04-24 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $51.57 | $1,082,979 | 1,994,681 (Indirect Direct) | View |
| 2020-04-09 Sale | 2020-04-13 7:16 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 12,208 | $47.6 | $581,086 | 2,015,681 (Indirect Direct) | View |
| 2020-04-06 Sale | 2020-04-08 7:21 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $44.87 | $2,490,476 | 2,027,889 (Indirect Direct) | View |
| 2020-03-26 Sale | 2020-03-27 6:27 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $46.03 | $529,372 | 2,083,389 (Indirect Direct) | View |
| 2020-03-23 Sale | 2020-03-25 6:47 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 31,792 | $43.11 | $1,370,451 | 2,094,889 (Indirect Direct) | View |
| 2020-03-10 Sale | 2020-03-12 8:40 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 44,000 | $40.84 | $1,796,843 | 2,126,681 (Indirect Direct) | View |
| 2020-02-24 Sale | 2020-02-26 8:20 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 21,000 | $52.16 | $1,095,422 | 2,170,681 (Indirect Direct) | View |
| 2020-02-13 Sale | 2020-02-14 4:22 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 11,500 | $61.84 | $711,137 | 2,082,517 (Indirect Direct) | View |
| 2020-02-10 Sale | 2020-02-12 7:31 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 55,500 | $64.03 | $3,553,744 | 2,094,017 (Indirect Direct) | View |
| 2020-01-27 Sale | 2020-01-29 7:37 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 21,000 | $58.25 | $1,223,284 | 2,149,517 (Indirect Direct) | View |
| 2020-01-15 Sale | 2020-01-17 5:10 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 11,500 | $53.12 | $610,853 | 2,170,517 (Indirect Direct) | View |
| 2020-01-10 Sale | 2020-01-14 7:17 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 55,500 | $54.7 | $3,036,046 | 2,182,017 (Indirect Direct) | View |
| 2019-12-18 Sale | 2019-12-20 6:29 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 48,500 | $60.92 | $2,954,577 | 2,237,517 (Indirect Direct) | View |
| 2019-12-13 Sale | 2019-12-17 9:09 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 41,500 | $58.95 | $2,446,620 | 2,286,017 (Indirect Direct) | View |
| 2019-12-10 Sale | 2019-12-12 7:54 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 34,500 | $53.88 | $1,858,709 | 1,026,219 (Indirect) | View |
| 2019-12-05 Sale | 2019-12-09 8:44 pm | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 118,500 | $51.77 | $6,134,753 | 2,362,017 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 101,084 | $5.12 | 2,682,275 (Indirect) | View |
| 2019-12-27 Exercise | 2020-02-26 8:18 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 8,080 | $3.2 | 2,682,275 (Indirect) | View |
| 2019-06-27 Exercise | 2020-02-26 8:18 pm | N/A 2028-11-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Director | 109,164 | $0 | 2,682,275 (Indirect) | View |
| 2020-01-06 Option Award | 2020-01-08 4:16 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Cui Jingrong Jean Chief Scientific Officer | 55,000 | $0 | 55,000 (Direct) | View |